Results
1 -
5 of
5
(Click
here to explore results)
- Selective inhibitors of phosphodiesterases: therapeutic promise for neurodegenerative disorders. Tarana Umar, Nasimul Hoda
, Med. Chem. Commun.
, 2015
, 6
, 2063
- Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds. Zhe Li, Xiao Lu, Ling-Jun Feng, Ying Gu, Xingshu Li, Yinuo Wu, Hai-Bin Luo
, Mol. BioSyst.
, 2015
, 11
, 115
- Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6. Alexandria M. Chan, Steven Fletcher
, RSC Med. Chem.
, 2021
, 12
, 178
- Review on anti-alzheimer drug development: approaches, challenges and perspectives. Abdallah E. Abdallah
, RSC Adv.
, 2024
, 14
, 11057
- Elucidation of fluorine's impact on pK
a and in vitro Pgp-mediated efflux for a series of PDE9 inhibitors. Kasper Fjelbye, Mauro Marigo, Rasmus P. Clausen, Erling B. Jørgensen, Claus T. Christoffersen, Karsten Juhl
, Med. Chem. Commun.
, 2018
, 9
, 893